Studies
Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.
Submitter: René Hänsel
Investigation: MegaCHOEP Phase III
Resources: No Resources
Study type: Not specified
Baseline Data and Endpoints for MAXSEP
Submitter: René Hänsel
Investigation: MAXSEP
Resources: MAXSEP Trial Data, MAXSEP Trial Metadata
Study type: Not specified
Baseline Data and Endpoints for HYPRESS
Submitter: Christoph Beger
Investigation: HYPRESS
Resources: HYPRESS Trial Data, HYPRESS Trial Metadata
Study type: Not specified
Baseline Data and Endpoints for SISPCT
Submitter: René Hänsel
Investigation: SISPCT
Resources: SISPCT Trail Data, SISPCT Trail Metadata
Study type: Not specified
Baseline Data and Endpoints for VISEP
Submitter: René Hänsel
Investigation: Efficacy of Volume Substitution and Insulin The...
Resources: VISEP metadata, VISEP trial data
Study type: Not specified
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 103
Submitter: René Hänsel
Investigation: Pegfilgrastim
Resources: Pegfilgrastim metadata, Pegfilgrastim trial data
Study type: Not specified
